Lab-Grown Meat Companies: The Complete Guide to Cultivated Protein (2026)
Cultivated meat -- real animal protein grown from cells, without slaughter -- has moved from science fiction to regulatory reality. Two companies (Upside Foods and GOOD Meat) have received both FDA and USDA approval in the United States. Israel has granted its first approvals. The EU is evaluating Novel Food applications. This guide profiles every major cultivated meat company, their technology, regulatory status, production costs, and path to commercial scale. Combined funding across the sector exceeds $1.6B.
| Company | HQ | Founded | Funding | Product | Regulatory Status | Stage |
|---|---|---|---|---|---|---|
| Upside Foods | Berkeley, CA | 2015 | $608M | Cultivated chicken | FDA GRAS + USDA grant of inspection (2023) | Limited commercial (US) |
| GOOD Meat (Eat Just) | San Francisco, CA | 2011 | $467M | Cultivated chicken | FDA GRAS + USDA (2023); Singapore Food Agency (2020) | Limited commercial (US, Singapore) |
| Aleph Farms | Rehovot, Israel | 2017 | $250M+ | Cultivated beef steaks | Israel regulatory approval (2024); Switzerland pending; US pending | Pre-commercial (regulatory clearance in Israel) |
| Mosa Meat | Maastricht, Netherlands | 2016 | $115M+ | Cultivated beef | EU Novel Food application pending; Singapore pending | Pre-commercial (pilot production) |
| SuperMeat | Tel Aviv, Israel | 2015 | $25M+ | Cultivated chicken | Israel regulatory approval pending; US pending | Pre-commercial (pilot facility) |
| Believer Meats | Rehovot, Israel (US HQ: Wilson, NC) | 2019 | $175M+ | Cultivated chicken, lamb | US FDA/USDA in process | Pre-commercial (largest facility under construction) |
| Year | Cost per Pound | Milestone | Context |
|---|---|---|---|
| 2013 | $1.2M | First lab-grown burger (Mark Post / Mosa Meat) | Proof of concept only |
| 2019 | $500-1,000 | Early startup prototypes | Small-scale bioreactors, FBS media |
| 2022 | $50-100 | Pilot plant production | Serum-free media, optimized cell lines |
| 2024 | $10-30 | Early commercial production | FDA/USDA approvals enable limited sales |
| 2026 (est.) | $7-15 | Scale-up phase | Larger bioreactors, cheaper media |
| 2028-2030 (target) | $5-8 | Price parity target | Commercial-scale facilities operational |
Cultivated meat in 2026 is past the question of "can it be done" and squarely at "can it be done at scale and at a price consumers will pay." The technology works. The regulatory path is clear in the US, Singapore, and Israel. The remaining challenge is manufacturing economics: reducing cell culture media costs by 10-50x, building bioreactor capacity at the 100,000+ liter scale, and achieving production costs below $10/pound.
The competitive landscape is splitting into two tiers. Tier 1 (Upside Foods, GOOD Meat, Believer Meats) has regulatory clearance or massive production facilities under construction. Tier 2 (Aleph Farms, Mosa Meat, SuperMeat) has strong technology but faces regulatory or scale-up bottlenecks. The winners will be companies that solve the media cost problem and build production capacity fastest.
For the broader cultivated protein market to reach mainstream adoption, production costs must fall to $5-8/pound (achievable by 2028-2030 at scale), taste must match conventional meat (most companies report near-parity in blind taste tests), and consumer acceptance must overcome the "ick factor" (surveys show 40-60% of consumers are willing to try cultivated meat). The sector is real, the products are real, and the question is now purely one of industrial scaling.